Chemoinformaics analysis of alpha-Neocallitropsene
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 39 |
| Exact Molecular Weight | 220.183 | nRing | 3 |
| Solubility: LogS | -5.141 | nHRing | 0 |
| Solubility: LogP | 4.04 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 0 | BPOL | 24.945 |
| QED | 0.204 |
| Synth | 7.849 |
| Natural Product Likeliness | 2.432 |
| NR-PPAR-gamma | 0.778 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.126 |
| HIA | 0.184 |
| CACO-2 | -5.266 |
| MDCK | 0.0000198 |
| BBB | 0.86 |
| PPB | 0.827567 |
| VDSS | 1.974 |
| FU | 0.0766201 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.994 |
| CYP2c19-inh | 0.802 |
| CYP2c19-sub | 0.546 |
| CYP2c9-inh | 0.952 |
| CYP2c9-sub | 0.004 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.023 |
| CYP3a4-inh | 0.948 |
| CYP3a4-sub | 0.949 |
| CL | 5.739 |
| T12 | 0.024 |
| hERG | 0.176 |
| Ames | 0.765 |
| ROA | 0.999 |
| SkinSen | 0.029 |
| Carcinogencity | 0.969 |
| EI | 0.018 |
| Respiratory | 0.974 |
| NR-Aromatase | 0.569 |
| Antiviral | Yes |
| Prediction | 0.851209 |